News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The company is known as one of the most reliable dividend payers in the stock market.
The FDA approved the first drug to treat a root cause of narcolepsy, which could help other sleep conditions as well.
Shopify shares gapped nearly 18% higher Wednesday
UGI narrows its fiscal Q3 loss and raises 2026 earnings guidance, even as revenues fall on weaker propane volumes across key operations.
Advanced nuclear startup Oklo achieved first criticality at its Groves Isotope Test Reactor in Texas in less than 12 months.
Wall Street is taking a "prove it" approach to PayPal's current valuation.
Analyst models for Phillips 66 have shifted, with fair value moving from US$194.11 to US$207.53 per share. This change lines up with recent research where many firms are lifting price targets, yet remain split on how much premium the stock should command and how long current refining conditions might last. Read on to see what is driving this evolving story around Phillips 66 and how you can track the changing narrative. Analyst Price Targets don't always capture the full story. Head over to...
CleanSpark, Inc. recently confirmed it will report its Q3 2026 results and hold its earnings call on August 6, 2026, as it faces revenue and EPS pressure from volatile Bitcoin prices and rising network difficulty. The company also entered a very large US$6.60 billion high-performance computing data center lease in Georgia, marking its biggest move yet into AI infrastructure and a clear effort to broaden its business beyond Bitcoin mining. We’ll now examine how CleanSpark’s very large US$6.60...
On Holding (NYSE:ONON) heads into its August 11, 2026 earnings report with two key storylines for investors: expectations for higher earnings and revenue, and a fresh co CEO structure. See our latest analysis for On Holding. On Holding’s recent 1-day share price return of 1.54% and 90-day share price return of 7.12% suggest building momentum ahead of earnings, even as the year to date share price return is down 18.66% and the 1-year total shareholder return is down 18.41%. If you are weighing...
Applied Materials (AMAT) is back in focus after Michael Burry disclosed fresh short positions against the stock and other AI linked semiconductor companies, alongside warnings of a possible sharp market reversal. See our latest analysis for Applied Materials. Applied Materials has been volatile around the US$534.24 share price, with the share price return falling 2.26% over the last day but rising 22.41% over seven days and 30.10% over ninety days. The 1 year total shareholder return of...
Nvidia is reportedly testing at least three Rubin Ultra variants with reduced HBM capacity.
Vistra (NYSE:VST) is being highlighted by industry analysts as a key potential beneficiary of SpaceX's aggressive buildout of AI infrastructure in the United States. SpaceX's planned expansion is expected to materially increase US power demand, which could raise the need for electricity infrastructure supplied by companies such as Vistra. Analysts view the direct link between a high profile hyperscale AI project like SpaceX's and suppliers including Vistra as a new driver of demand, in...
Advanced Micro Devices, Inc. (NASDAQ:AMD) is poised to benefit from the next phase of the AI infrastructure boom. This comes as chip demand expands beyond graphics processing units (GPUs) into central processing units (CPUs) and other data center products. According to a Reuters report on July 23, AMD and Intel Corp (NASDAQ:INTC) are negotiating longer-term […]
It's all part of the media giant's new streaming strategy.
Gas stations were just waypoints, but the warehouse giant has turned them into a competitive advantage that’s breaking records: Adam
A single ETF charging roughly four cents per $100 turned a modest investment into a small fortune over a decade, and the fee structure is the part of the story most investors never think to examine.
AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.
(Bloomberg) -- Nscale is telling prospective investors it has about $51 billion of total contracted revenue ahead of a US initial public offering that could take place as soon as in September, according to people familiar with the matter.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftWhy Do Data Centers Use So Much Fresh Water?Microsoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowOpenAI Models Joine
The purchase brings SpaceX's first-half spending on Tesla's battery storage systems to $329 million, filings show
As SpaceX stock has tumbled since its record-setting IPO, shares of newly public smaller companies have soared.
Last-mile delivery service reports 36% increase in revenue in Q2
FOX (NASDAQ:FOX) reported record fiscal 2026 revenue and EBITDA, as the company benefited from FIFA Men’s World Cup advertising, growth at Tubi and FOX One, and continued strength in its news and sports businesses. For the fiscal year ended 2026, revenue increased 5% to more than $17 billion, while
Fluence Energy (NASDAQ:FLNC) reported record third-quarter order intake and backlog growth, including its first signed data-center developer order, while lowering its fiscal 2026 revenue and adjusted EBITDA outlook because of delays ramping new manufacturing capacity. President and Chief Executive
Johnson and Johnson just committed over a billion dollars to flood the market with American-made contact lenses, but retirees banking on Medicare to share the cost are about to get a rude awakening at the pharmacy counter.
📣 “We have every expectation the transaction will close.” —Warner Bros. Discovery CEO David Zaslav, speaking to analysts today about Paramount's agreement to buy the company, which has faced legal challenges of late.
Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!
Arm Holdings has already traded near $450 this year, then lost nearly a quarter of its value in a month. Now Wall Street analysts are split on whether the AI compute giant can claw back those highs or if the real trouble is just beginning.